Philip Morris International (PM -4.3%) drops after a FDA panel rejects claims by the company that IQOS products reduce health risks.
Shares of Altria (MO -2.7%) are also reacting to the development.
The story is still developing. Further updates will be posted.
Now read: Altria: 5 Reasons To Buy »
Subscribe for full text news in your inbox